Novo Nordisk Inc. et al v. Meitheal Pharmaceuticals, Inc. et al
Novo Nordisk Inc. and Novo Nordisk A/S |
Meitheal Pharmaceuticals, Inc. and Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. |
1:2023cv01195 |
October 20, 2023 |
US District Court for the District of Delaware |
Colm F Connolly |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. ยง 271 Patent Infringement |
None |
Docket Report
This docket was last retrieved on December 18, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
SO ORDERED, re #11 Unopposed MOTION for Extension of Time to File Answer , move, or otherwise respond to the Complaint in this action to December 22, 2023, filed by Novo Nordisk A/S, Novo Nordisk Inc. Reset Answer Deadlines: Meitheal Pharmaceuticals, Inc. answer due 12/22/2023; Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. answer due 12/22/2023. Ordered by Judge Colm F. Connolly on 12/18/2023. (kmd) |
Filing 11 Unopposed MOTION for Extension of Time to File Answer , move, or otherwise respond to the Complaint in this action to December 22, 2023 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) |
Filing 10 Unopposed MOTION for Extension of Time to Respond to Complaint (D.I. 1) - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) |
SO ORDERED, re #10 Unopposed MOTION for Extension of Time to Respond to Complaint (D.I. 1), filed by Novo Nordisk A/S, Novo Nordisk Inc. Reset Answer Deadlines: Meitheal Pharmaceuticals, Inc. answer due 12/15/2023; Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. answer due 12/15/2023. Ordered by Judge Colm F. Connolly on 11/14/2023. (kmd) |
Filing 9 STANDING ORDER REGARDING BRIEFING IN ALL CASES (nmf) |
Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (nms) |
Filing 8 AFFIDAVIT of Service for Summons, Complaint and related papers served on Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. on October 23, 2023, filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) |
Filing 7 SUMMONS Returned Executed by Novo Nordisk Inc., Novo Nordisk A/S.Meitheal Pharmaceuticals, Inc. served on 10/23/2023, answer due 11/13/2023. (Egan, Brian) |
Filing 6 Summons Issued as to Meitheal Pharmaceuticals, Inc. on 10/20/2023; Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. on 10/20/2023. (Attachments: #1 Summons Issued) (vfm) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novo Nordisk A/S, Corporate Parent Novo Nordisk US Holdings Inc., Corporate Parent Novo Nordisk Commercial Holdings, Inc. for Novo Nordisk Inc.; Corporate Parent Novo Nordisk Foundation, Corporate Parent Novo Holdings A/S for Novo Nordisk A/S filed by Novo Nordisk A/S, Novo Nordisk Inc.. (vfm) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,114,833 B2 ;9,265,893 B2. (vfm) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/08/2023. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 3/8/2026. (vfm) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) |
Filing 1 COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Meitheal Pharmaceuticals, Inc., Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. ( Filing fee $ 402, receipt number ADEDC-4254543.) - filed by Novo Nordisk Inc., Novo Nordisk A/S. (Attachments: #1 Exhibit A-B, #2 Civil Cover Sheet) (vfm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.